- Report
- October 2024
- 183 Pages
Global
From €3370EUR$3,545USD£2,831GBP
€3745EUR$3,939USD£3,146GBP
- Report
- February 2025
- 149 Pages
Global
From €2851EUR$2,999USD£2,395GBP
- Report
- March 2025
- 372 Pages
Global
From €4706EUR$4,950USD£3,953GBP
- Report
- March 2025
- 200 Pages
Global
From €4268EUR$4,490USD£3,586GBP
- Report
- July 2024
- 100 Pages
Global
From €3565EUR$3,750USD£2,995GBP
- Report
- May 2024
- 200 Pages
Global
From €3945EUR$4,150USD£3,314GBP
- Report
- October 2024
- 200 Pages
Global
From €4705EUR$4,949USD£3,952GBP
- Report
- July 2024
- 158 Pages
Global
From €4040EUR$4,250USD£3,394GBP
- Report
- August 2024
- 122 Pages
Global
From €3803EUR$4,000USD£3,195GBP
- Report
- March 2025
- 182 Pages
Global
From €4706EUR$4,950USD£3,953GBP
- Report
- February 2025
- 200 Pages
Global
From €4268EUR$4,490USD£3,586GBP
- Report
- January 2025
- 429 Pages
Global
From €4706EUR$4,950USD£3,953GBP
- Report
- March 2025
- 196 Pages
Global
From €3370EUR$3,545USD£2,831GBP
€3745EUR$3,939USD£3,146GBP
- Report
- March 2025
- 188 Pages
Global
From €3370EUR$3,545USD£2,831GBP
€3745EUR$3,939USD£3,146GBP
- Report
- October 2024
- 185 Pages
Global
From €3370EUR$3,545USD£2,831GBP
€3745EUR$3,939USD£3,146GBP
- Report
- October 2024
- 195 Pages
Global
From €3370EUR$3,545USD£2,831GBP
€3745EUR$3,939USD£3,146GBP
- Report
- October 2024
- 193 Pages
Global
From €3370EUR$3,545USD£2,831GBP
€3745EUR$3,939USD£3,146GBP
- Report
- October 2024
- 197 Pages
Global
From €3370EUR$3,545USD£2,831GBP
€3745EUR$3,939USD£3,146GBP
- Report
- October 2024
- 180 Pages
Global
From €3370EUR$3,545USD£2,831GBP
€3745EUR$3,939USD£3,146GBP
- Report
- October 2024
- 192 Pages
Global
From €3370EUR$3,545USD£2,831GBP
€3745EUR$3,939USD£3,146GBP

The Ventricular Assist Device (VAD) market is a subset of the Cardiovascular Devices market. VADs are mechanical pumps that are implanted in the body to help the heart pump blood. They are used to treat heart failure, bridge patients to heart transplantation, and provide long-term support for patients with end-stage heart failure. VADs are typically used in patients who are not eligible for heart transplantation or who are waiting for a donor heart.
VADs are classified into two main categories: left ventricular assist devices (LVADs) and right ventricular assist devices (RVADs). LVADs are used to support the left ventricle, while RVADs are used to support the right ventricle. Both types of VADs are designed to improve the quality of life of patients with heart failure.
Some companies in the VAD market include Abiomed, Medtronic, Thoratec, and SynCardia. Show Less Read more